IP Library Granted Patent US 7,005,071
Granted Patent B2
US 7,005,071 · App. 10/699,058 · Granted Feb 28, 2006

Method of generating metal chelating affinity ligands

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,005,071
App. No.
10/699,058
Granted
Feb 28, 2006
Kind
B2
Abstract

The present invention relates to a method of generating at least one polydentate metal chelating affinity ligand, which method comprises the steps of a) providing at least one cyclic scaffold comprising a carbonyl, an adjacent sulphur and a nucleophile; b) providing at least one polydentate metal chelating affinity ligand arm, optionally in a form wherein the metal chelating functionalities are protected, on each scaffold by derivatisation of the nucleophile of said scaffolds, while retaining the cyclic structure of the scaffold; (c) ring-opening at the bond between the carbonyl and the sulphur of the derivatized scaffold by adding a reagent that adds one or more metal chelating affinity ligand arms to the scaffold; and, if required, (d) deprotecting the functionalities of the ligand arm(s) provided in step (b). In the most preferred embodiment of the method, steps (c) and (d) are performed simultaneously as one single step.

Claims (22)

1. A method of generating at least one polydentate metal chelating affinity ligand, which method comprises the steps of

(a) providing at least one scaffold defined by a ring of the general formula (I)

 wherein

X 1 , X 2 and X 3 irrespective of each other are sp 2 - or sp 3 -hybridised carbon atoms or heteroatoms,

X 4 is a nucleophile and m is an integer of 0–2;

(b) providing at least one polydentate metal chelating affinity ligand arm on each scaffold by derivatisation of the nucleophilic X 4 groups of said scaffolds while retaining the cyclic structure of the scaffold; and

(c) opening the ring at a bond between the carbonyl and the sulphur of the derivatised scaffold by adding a reagent that adds one or more metal chelating affinity ligand arms to the scaffold.

2. The method of claim 1 , wherein in formula (I), X 1 , X 2 and X 3 are carbon atoms.

3. The method of claim 1 , wherein in formula (I), X 4 is —NH 2 .

4. The method of claim 1 , wherein in formula (I), m is 1 and the scaffold is homocysteine thiolactone.

5. The method of claim 1 , wherein in step (b), the derivatisation is provided by adding at least one derivatisation agent comprised of one part, which is electrophilic and hence capable of reacting with X 4 in Formula (I), and a second part, which is a metal chelating affinity ligand.

6. The method of claim 5 , wherein the derivatisation is provided by adding two derivatisation agents, which comprise two different or identical metal chelating functionalities.

7. The method of claim 5 , wherein said at least one derivatisation agent is a halogenated, protected ester.

8. The method of claim 7 , wherein said at least one derivatisation agent is bromo-acetic acid ethyl ester.

9. The method of claim 1 , wherein in step (c), ring-opening is hydrolysis provided by adding a base.

10. The method of claim 1 , wherein the metal chelating affinity ligand arms are protected in step (b).

11. The method of claim 10 , further comprising the steps of deprotecting the chelating affinity ligand arms after step (c) and coupling the resultant compound via its thiol group to a base matrix in order to produce a separation medium.

12. The method of claim 11 , wherein the thiol group is coupled to allyl groups of the base matrix.

13. The method of claim 11 , further comprising a step of allylating the base matrix to provide reactive groups to permit said coupling.

14. The method of claim 11 , wherein the thiol group of the ligand is coupled to the base matrix via an allyl group of allyl glycidyl ether (AGE).

15. The method of claim 11 , further comprising a step of activating the reactive groups of the base matrix.

16. The method of claim 15 , wherein the activating is performed by bromination.

Assignments (4)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2003
From: ANDERSON, LARS C.; TEDEBARK, ULF; GEBRU, TESFAI; AXEN, ANDREAS; MALOISEL, JEAN-LUC
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 014664/0685 →